Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Non-Current Assets (2011 - 2026)

Updated

Adma Biologics (ADMA) reported Non-Current Assets of $156.01 million for Q2 2026, down 1.8% from $158.82 million a year earlier but up 1.3% from the prior quarter.

Analysis

Adma Biologics (ADMA) Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Adma Biologics posted Non-Current Assets of $157.73 million, up 0.3% from FY2024.

  • Non-Current Assets has a five-year compound annual growth rate of 23.9% (FY2020 to FY2025).
  • By year, Non-Current Assets came in at $157.27 million in FY2024 (+117.9%), $72.17 million in FY2023 (-7.5%), $78.06 million in FY2022 (+15.6%) and $67.52 million in FY2021 (+25.2%).
  • Five-year quarterly Non-Current Assets spans a low of $63.86 million in Q3 2021 and a high of $166.03 million in Q3 2025.
  • Year over year, Non-Current Assets gained in five of the last eight quarters, with growth averaging 58.8%.
  • The high point for year-over-year Non-Current Assets in five years was Q3 2025 (growth of 129.2%); the low point was Q4 2023 (a decline of 7.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $154.01 million (Q1 2026), $157.73 million (Q4 2025) and $166.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 156.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.01 Mn
Mar 31, 2026 154.01 Mn
Dec 31, 2025 157.73 Mn
Sep 30, 2025 166.03 Mn
Jun 30, 2025 158.82 Mn
Mar 31, 2025 158.76 Mn
Dec 31, 2024 157.27 Mn
Sep 30, 2024 72.43 Mn
Jun 30, 2024 72.71 Mn
Mar 31, 2024 74.46 Mn
Dec 31, 2023 72.17 Mn
Sep 30, 2023 75.30 Mn
Jun 30, 2023 76.78 Mn
Mar 31, 2023 76.70 Mn
Dec 31, 2022 78.06 Mn
Sep 30, 2022 76.46 Mn
Jun 30, 2022 74.16 Mn
Mar 31, 2022 68.23 Mn
Dec 31, 2021 67.52 Mn
Sep 30, 2021 63.86 Mn
API Access

Adma Biologics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ADMA&period=max&api_key=YOUR_API_KEY